Abstract
In fiscal 1969 a total of $45.5 million was committed by U.S. sources to contraceptive research and development. Federal agencies voluntary agencies (principally the Ford and Rockefeller foundations and the Population Council) and the drug industry provided $19.9 million $8.5 million and $17.2 million respectively. An additional $5.4 million was committed by U.S. sources to study the side effects of contraceptives. The federal government only recently became the leading source of support for contraceptive research and development. The federal agencies principally involved are the National Institutes of Health and the Agency for International Development. Most contraceptive researchers feel that research should proceed simultaneously in reproductive biology and contraceptive technology. Current recommended areas of research in the field include the minipill sterilization methods sperm inhibition rhythm method effectiveness IUD improvement injections or implants under the skin of low-dose progestins the once-a-month pill (hopefully with prostaglandins) and inhibition of hormonal releasing factors. The government should press harder for major new advances in contraception.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
